Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sphingolipid metabolism during human platelet activation.

C G Simon1, A R Gear

  • 1Department of Biochemistry & Molecular Genetics, University of Virginia, School of Medicine, Charlottesville 22908, USA.

Thrombosis Research
|April 23, 1999
PubMed
Summary

This study investigated ceramide

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthogonal and complementary measurements of properties of drug products containing nanomaterials.

Journal of controlled release : official journal of the Controlled Release Society·2022
Same author

A method for the evaluation of thousands of automated 3D stem cell segmentations.

Journal of microscopy·2015
Same author

Imaging cells on polymer spherulites.

Journal of microscopy·2004
Same author

Local anesthetic actions on thromboxane-induced platelet aggregation.

Anesthesia and analgesia·2001
Same author

ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC.

FEBS letters·2001
Same author

Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function.

Blood·2001

Area of Science:

  • Biochemistry
  • Hematology
  • Cell Signaling

Background:

  • Thrombin-activated platelets release sphingosine-1-phosphate, a known platelet aggregation potentiator.
  • Sphingolipids, like ceramide, are implicated in cellular signaling pathways relevant to platelet function.
  • Platelets possess sphingomyelinase activity, capable of producing ceramide from sphingomyelin.

Purpose of the Study:

  • To determine if ceramide levels change during human platelet activation by thrombin.
  • To investigate the potential role of ceramide as a second messenger in platelet aggregation.

Main Methods:

  • Analysis of ceramide and sphingomyelin levels in resting and thrombin-activated human platelets using thin-layer chromatography.
  • Quantification of total mass and radiolabeled (14C-palmitate, 14C-serine) ceramide and sphingomyelin pools.
  • Assessment of sphingomyelinase activity by measuring 14C-phosphocholine production from labeled sphingomyelin.

Main Results:

  • No significant alterations in ceramide or sphingomyelin concentrations were observed upon platelet activation.
  • Platelet activation did not result in the hydrolysis of labeled sphingomyelin, indicating no significant sphingomyelinase activity.
  • Evidence suggests ceramide is not produced or does not accumulate during thrombin-induced platelet activation.

Conclusions:

  • Ceramide does not appear to function as a second messenger in thrombin-mediated human platelet aggregation.
  • The study's findings exclude a direct role for ceramide in the signaling pathways of platelet activation.
  • Further research may be needed to explore other sphingolipids or signaling molecules in platelet function.

Related Experiment Videos